Evidence map›Paper›PMID 36640218›Full record

ReviewCurrent diabetes reports2023

Recent Rates of Substance Use Among Adolescents and Young Adults with Type 1 Diabetes in the USA.

Rachna Sannegowda, Karina Villalba, Ryan Suk, Shilpa Gurnurkar, Rachel M Wasserman

Open access · bronzeAbstract readReview
In one paragraph

Review in Current diabetes reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Beyond HbAFrontiers in endocrinology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Rachna SannegowdaUniversity of Central Florida College of Medicine, Orlando, FL, USA.
Karina VillalbaUniversity of Central Florida College of Medicine, Orlando, FL, USA.
Ryan SukDepartment of Management, Policy, and Community Health, University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA.
Shilpa GurnurkarDivision of Endocrinology, Nemours Children's Hospital- Florida, Orlando, FL, USA.
Rachel M WassermanCenter for Healthcare Delivery Science, Nemours Children's Health, 6700 Lake Nona Boulevard, Orlando, FL, USA. Rachel.Wasserman@nemours.org.ORCID 0000-0003-2548-1886
University of Central Florida · USNemours Children's Clinic · USNemours Children's Health System · USThe University of Texas Health Science Center at Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewSubstance use is a major public health problem in adolescents and young adults (AYA) and is particularly dangerous for AYA with type 1 diabetes (T1D) due to additional health consequences related to T1D. Rates of substance use among AYA with T1D are difficult to ascertain. Currently, we aim to provide a summary of published rates of substance use, over the last 10 years, among AYA with T1D in the USA. RECENT

findingsThis review included a database search, abstract screening, and synthesizing of articles published in the last 10 years that reported rates of substance use among AYA with T1D. We also compared rates to national survey data from the Center for Disease Control and Substance Abuse and Mental Health Services Administration. Of 138 articles, 123 abstracts were excluded due to non-relevance or because they were conducted outside of the USA; 15 articles were evaluated, and 8 provided original data on AYA with T1D. These 8 studies were summarized and compared to nationwide survey data. Most of the published rates of substance use among AYA with T1D were similar to national survey data for alcohol, tobacco, and marijuana. Rates of illicit drug use were lower among AYA with T1D. Despite additional health consequences, alcohol, tobacco, and marijuana use is about as prevalent among AYA with T1D as in the general US population. These findings emphasize the importance of conducting more research in this area, developing effective interventions, and incorporating prevention into standard clinical practices.

Indexed as

CannabisDiabetes Mellitus, Type 1Substance-Related DisordersAdolescentHumansSurveys and QuestionnairesYoung AdultAdolescentsSubstance useType 1 diabetesYoung adults

Identifiers

PMID36640218
PMCPMC9839951
OpenAlexW4316096062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.